Several modifications in CA-4 were reported in literature for the development of various tubulin inhibitors. In our study, twenty-two newly synthesized heterocyclic derivatives of Combretastatin A-4 (CA-4) have been tested for their cytotoxic effect on four different types of cells with malignant behavior using CA-4 as a positive control. Compounds 5b, 15 and 16 showed the foremost potent antiproliferative activities as compared to CA-4 with IC50 starting from 6.9 to 13.7 μM. Molecular docking was performed with the crystal structure of tubulin employing a potent tubulin inhibitor CA-4 as a parent molecule. Molecular study advised that 5b, 15, 16 and 17 are promising tubulin inhibitors.
Introduction
Microtubule-targeting agents are used clinically as antitumor drugs. Their anticancer activity is commonly due to tubulin inhibition. They prevent the formation of microtubule, thus affecting cellular replication and shape [1] . In general, antitubulin agents bind with five totally different binding pockets on the β-tubulin subunit [2] . Agents that strongly react with colchicine binding site induce depolymerization of tubulin, therefore they inhibit tubulin action [3] (Figure 1(a) ).
This study will focus on agents that target colchicine-binding site [4] .
The natural product CA-4 that is under investigation as it has a strong affinity to colchicine binding site, and therefore a strong tubulin inhibitor. Thus, we use CA-4 as a lead molecule for synthesis of new derivatives and more studied as tubulin inhibitors [5] . It is formed of three parts (2 carbons bridge, ring A and ring B) [6] (Figure 1(b) ). Various changes to CA-4 structure have been performed in literature. The changes to the central bridge affect the cytotoxic activity the most [7] - [15] . Ring A has received little or no attention while ring B has received larger attention. Impressed by these finding, the double bond of CA-4 is substituted by α, β-unsaturated ketone, pyrazole, quinoline-3-carbonitriles, fused pyrimidine, fused quinazoline moieties, imine derivatives and 2-amino-4H-chromenes. Besides, ring A and B are replaced by 1, 5-diphenylpyrazole, naphthalene and pyrazole moieties.
Those were evaluated in vitro for their anticancer tendency toward four cancer cell types. Additionally, molecular docking studies are performed and compared to biological results.
Materials and Methods

Chemistry
The new compounds are prepared by different pathways described in Scheme 1 and Scheme 2. The starting compound 3 was obtained via Vilsmeir Haack's formylation of the pyrazole derivatives using POCl 3 /DMF [16] . The α, β unsaturated carbonyl derivatives 4a, 4b were synthesized via Claisen-Schmidt condensation [17] of cyclic ketones 4a, b with substituted pyrazole-4-carbaldehyde 3 in an ethanolic solution of sodium hydroxide [18] [19] [20] [21] [22] . Cyclocondensation of enone 4a with hydrazine hydrate or phenyl hydrazine using ethanol or glacial ethanoic acid afforded pyrazoles 5a-c [23] . Scheme 1. Reagents and conditions: (a) cyclohexanone or N-methyl piperidone, alchoholic NaOH; (b) NH 2 NHR, absolute ethanol or NH 2 NH 2 , AcOH; (c) malononitrile, sodium methoxide, sodium ethoxide or sodium propoxide, methanol, ethanol or n-propanol; (d) malononitrile, ammonium acetate, absolute ethanol; (e) ethylcyanoacetate, ammonium acetate, absolute ethanol; (f) POCl 3 \DEA; (g) thiourea, Na metal, butanol; (h) 2-aminothiazole, AcOH. malononitrile with compounds 4a in sodium alkoxide to give the corresponding 2-alkoxyquinoline-3-carbonitriles derivatives 6a-c. Furthermore, a reaction of chalcone 4a with malononitrile and ammonium acetate in ethanol gave 2-aminoquinoline-3-carbonitrile derivative 7. Also, 2-oxoquinoline-3-carbonitrile was prepared from condensation of compound 3 with malononitrile in ethamalononitrile derivative 14 with naphthols using methanesulfonic acid [26] . Also, it was found that 5-amino-4-cyanopyrazole analogue 17 resulted when two moles of malononitrile derivative 14 condensed with one mole of hydrazine hydrate in absolute ethanol. All the analytical and spectroscopic data of the prepared compounds were fully accordance with their represented structures.
Biology
Four neoplastic cell types namely; (MCF-7), (HCT-116), (Hela) and (PC3) are obtained through VACSERA, Cairo, Egypt. Combretastatin A-4 was used as ref-
erence for judgment on anticancer activity of newly synthesized molecules.
The reagents RPMI-1640 medium, MTT, DMSO and CA-4 (sigma co., St.
Louis, USA), Fetal Bovine blood serum (GIBCO, UK) [27] .
The MTT assay was applied to assess cytotoxic activity using the cell lines mentioned above. 
Molecular Modeling
The docking studies and modeling calculations were done using MOE version 2008.10 release of Chemical Computing Groups using Windows XP software.
The 3D structures of the synthesized molecules were built using Chem Biooffice suite then saved as Mol 2 format with the help of MOE software, then subjected to docking simulation. The three dimensional X-ray structure of protein (PDB code: 1SA1) was obtained from the Protein Data Bank.
Results
Antitumor Activity
All the synthesized compounds were evaluated for their cytotoxic activity toward a panel of 4 human neoplastic cell lines using the MTT assay. The results, in Table 1 showed that every compound have antitumor activities with noticeable differences due to structural variations.
As shown in Table 1 , compound 5b with 2-phenyl substituted indazole International Journal of Organic Chemistry shows wide spectrum cytotoxic activity with IC50 starting from 6.9 to 12.7 μM.
Replacement of phenyl ring with acetyl group as in compound 5c or unsubstituted indazole in compound 5a and uncyclized chalcone as in compound 4a exhibited a decrease within the activity against the four cell lines. Additionally, the cytotoxic activities of recent synthesized quinoline-3-carbonitrile 6-9, compounds 6a with 2-methoxy and 6c with 2-propoxy group has broad spectrum activity virtually identical IC50, (22.6 ± 1.87 for HCT-116, 14.9 ± 1.23 for Hela, 
Molecular Modeling
Molecular docking was performed for compounds that inhibited tubulin polymerization so as to explore attainable binding modes. The tubulin protein structure in complex with podophyllotoxin (PDB 1SA1) was used for the study 
Experimental
Melting points (˚C) were recorded using a Fisher-Johns melting point apparatus and are uncorrected. 
General Procedure for Synthesis of 5a, c
Hydrazine hydrate (98%) (0.3 ml, 0.05 mol) introduced to a solution of 4a in ethyl alcohol (99%) (20 ml) 5a or ethanoic acid (10 ml) 5c and the mixture was refluxed for 5 h. The solvent was decreased using evaporator. After cooling the separated product was filtered, dried and finally recrystallized from ethyl alcohol.
General Procedure for Synthesis of 5b
A mixture of chalcone 4a (0. 
Preparation of 6a-c
A mixture of compound 4a (0.6 g, 1 mmol) and malononitrile (0.07 g, 1 mmol) was added to freshly prepared solution of sodium alkoxide (15 ml), (0.3 g, 0.014 mol) of sodium in 100 ml of the appropriate alcohol. The mixture kept at room temperature for the ideal time. The triggered product became collected by filtration, washed with ethanol and recrystallized from ethanol/ DMF. 
Preparation of 4-(3-Methyl-1,5-Diphenyl-1H-Pyrazol-4-yl)-8-(E)
[
Preparation of 10a, b
The α, β-unsaturated ketone 4a or 4b (0.01 mol) was mixed with thiourea (0. 
Preparation of 12a, b and 13
A mixture of compound 3 (2 g, 0.1 mol) and appropriate aromatic amine in glacial ethanoic acid ( Mixture of methyl-1, 5-diphenyl-1H-pyrazole-4-carbaldehyde 3 (3.5 g, 1 mol), malononitrile (0.9 g, 1 mol), in ethyl alcohol 95% (20 ml) were refluxed for 12 h.
After of entirety of the reaction with the aid of TLC, the mixture changed into cooling to 25˚C, filtered and washed with water. The resulting solid product was recrystallized from methanol to yield compound 14 as pure yellow crystals 75% 
Preparation of 15, 16
Mixture of compound 14 (3.5 g, 1 mmol), the appropriate naphthol (1 mmol) and methanesulfonic acid (1.2 g, 1 mmol) in acetonitrile (5 ml) were refluxed for 5 h. After completion of the reaction, the aggregate turned into cooling to room temperature and filtered. The filtrate wad washed by 5% NaHCO 3 and dried over 
Preparation of 17
A solution of compound 16 (4.6 g, 2 mol) in15 ml of ethanol was added to 80% hydrazine hydrate (0.6 ml, 1 mol). The mixture was stirred at 25˚C for 4 hrs, the solvent was evaporated under reduced pressure. The residue was washed with ethyl alcohol, recrystallized from the water. 
Conclusion
A series of new compounds have been synthesized using efficient methods and tested for their biological activities. There is a strong correlation between molecular modeling and biological screening results which suppose that the structural modification of the lead structure affects the activity in a predictable manner;
as shown in (Figures 2-6 ), CA-4 shows highest binding affinity with its methoxy 
